• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB 5.97% 31.5¢

DIMERIX LIMITED

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing new therapies in areas with unmet medical needs for global markets. It is focused on developing its products, DMX-200, for Focal Segmental Glomerulosclerosis (FSGS), respiratory complications associated with COVID-19 and Diabetic Kidney Disease and is developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its DMX-200 and DMX-700 are identified using its assay, Receptor Heteromer Investigation Technology (Receptor-HIT), which is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. It has completed two Phase 2 studies: one in FSGS and one in diabetic kidney disease. Receptor-HIT is licensed to Excellerate Bioscience.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DXB
Dimerix (ASX: DXB) Discussion Thread
9 10 11
11:20 624 195K
11:20 Last post  kensington Comments Created with Sketch.  624  Views Created with Sketch.  195K 
DXB
DJ Dimerix Initiated at A$0.80/Share Price Target by Euroz Hartleys
09:23 11 4.0K
09:23 Last post  TheBrownHornet Comments Created with Sketch.  11  Views Created with Sketch.  4.0K 
DXB
DXB Chart
12 13 14
25/04/24 806 274K
TRENDING NEWS

Hillcrest's ZVS Technology Gains Traction in New Applications, Fuels Growth

NEWS
26 Apr 2024
25/04/24 Last post  RYNZN Comments Created with Sketch.  806  Views Created with Sketch.  274K 
DXB 24/04/24 48 12K
24/04/24 Last post  kdwc Comments Created with Sketch.  48  Views Created with Sketch.  12K 
DXB 22/04/24 0 360
22/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  360 
DXB 13/04/24 2 1.3K
13/04/24 Last post  frenchfries57 Comments Created with Sketch.  2  Views Created with Sketch.  1.3K 
DXB 10/04/24 0 358
10/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  358 
DXB
DXB Media thread.
2 3
09/04/24 125 48K
09/04/24 Last post  Jayze87 Comments Created with Sketch.  125  Views Created with Sketch.  48K 

See All Discussions arrow Created with Sketch.

Timeline

Application for quotation of securities - DXB
22 Apr 11:21
 
Quarterly Appendix 4C and Activities Report
22 Apr 08:45
 
Notification of cessation of securities - DXB
12 Apr 10:26
 
Application for quotation of securities - DXB
10 Apr 10:37
 
Change of Director's Interest Notice - SP
08 Apr 13:28
 
Notification of cessation of securities - DXB
05 Apr 08:59
 
View More arrow Created with Sketch.
(20min delay)
Last
31.5¢
Change
-0.020(5.97%)
Mkt cap ! $175.8M
Open High Low Value Volume
33.0¢ 33.5¢ 31.5¢ $887.3K 2.743M

Buyers (Bids)

No. Vol. Price($)
8 872451 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.5¢ 126000 7
View Market Depth
Last trade - 13.53pm 26/04/2024 (20 minute delay) ?
Last
31.5¢
  Change
-0.020 ( 4.66 %)
Open High Low Volume
33.5¢ 33.5¢ 31.5¢ 1968787
Last updated 14.14pm 26/04/2024 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.